--- title: "Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings" type: "News" locale: "en" url: "https://longbridge.com/en/news/298346901.md" description: "U.S. stocks fell Tuesday, with the Dow down 1.06% and S&P 500 down 0.36%, as healthcare lagged while energy gained 1.6%. ABM Industries beat Q3 earnings estimates. Biotech shares saw volatility: PDSB surged 65% on funding news, while Dyne Therapeutics dropped 23% and Novartis fell 13% on trial results. Oil rose 1.5% to $92.88. European and Asian markets were mixed or lower." datetime: "2026-09-08T16:02:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/298346901.md) - [en](https://longbridge.com/en/news/298346901.md) - [zh-HK](https://longbridge.com/zh-HK/news/298346901.md) generator: "portal-rs" --- # Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings U.S. stocks traded lower midway through trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 1.06% to 52,849.66 while the NASDAQ dipped 0.12% to 26,476.11. The S&P 500 also fell, dropping, 0.36% to 7,690.48. **Leading and Lagging Sectors** Energy shares jumped by 1.6% on Tuesday. In trading on Tuesday, health care stocks fell by 2%. **Top Headline** **ABM Industries Inc** (NYSE:ABM) posted better-than-expected earnings for the third quarter on Tuesday. The company posted adjusted earnings of $1.04 per share, beating market estimates of $1.01 per share. The company’s sales came in at $2.317 billion, versus expectations of $2.310 billion. **Equities Trading UP** - **PDS Biotechnology Corp (**NASDAQ:PDSB) shares shot up 65% to $0.36 after the company announced it raised up to $22.55 million in equity funding in a Private Investment in Public Equity transaction. - Shares of **Roivant Sciences Ltd** (NASDAQ:ROIV) got a boost, surging 17% to $40.91 after the company shared topline data from its Phase 2 PHocus clinical trial evaluating mosliciguat for pulmonary hypertension associated with interstitial lung disease (PH-ILD). - **Pharvaris NV (**NASDAQ:PHVS) shares were also up, gaining 17% to $41.30 after the company announced statistically significant and clinically meaningful topline results of the CHAPTER-3 pivotal Phase 3 study evaluating deucrictibant extended-release tablet for the prevention of HAE attacks. **Equities Trading DOWN** - **Dyne Therapeutics, Inc (**NASDAQ:DYN) shares dropped 23% to $18.76. Dyne Therapeutics will present preclinical data for multiple development candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting. - Shares of **Novartis AG (**NYSE:NVS) were down 13% to $139.95 after the company disclosed that the pelacarsen phase III Lp(a) HORIZON trial did not meet its primary endpoint. - **Lexaria Bioscience Corp** (NASDAQ:LEXX) was down, falling 35% to $9.22 after the company announced a warrant inducement repricing of 453,969 warrants to $12.92 per share from the original prices of $17.85 to $45.90. **Commodities** In commodity news, oil traded up 1.5% to $92.88 while gold traded down 0.8% at $4,443.00. Silver traded up 0.1% to $66.795 on Tuesday, while copper rose 2.5% to $6.8525. **Euro zone** European shares were mixed today. The eurozone’s STOXX 600 rose 0.01%, while Spain’s IBEX 35 Index fell 0.24%, London’s FTSE 100 rose 0.21%, Germany’s DAX slipped 0.12%, while France’s CAC 40 gained 0.05%. **Asia Pacific Markets** Asian markets closed mostly lower on Tuesday, with Japan’s Nikkei 225 dipping 1.70%, Hong Kong’s Hang Seng index falling 0.38%, China’s Shanghai Composite gaining 0.20% and India’s BSE Sensex dipping 0.73%. **Economics** - The Manheim Used Vehicle Value Index declined 0.9% month-over-month in August, recording a second straight monthly decline. - The US NFIB Small Business Optimism Index declined to 98.7 in August from 99.8 in the previous month and also missing market estimates of 99.3. *Photo via Shutterstock* ### Related Stocks - [DYN.US](https://longbridge.com/en/quote/DYN.US.md) - [PDSB.US](https://longbridge.com/en/quote/PDSB.US.md) - [ABM.US](https://longbridge.com/en/quote/ABM.US.md) - [NVS.US](https://longbridge.com/en/quote/NVS.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [USO.US](https://longbridge.com/en/quote/USO.US.md) - [03097.HK](https://longbridge.com/en/quote/03097.HK.md) - [UCO.US](https://longbridge.com/en/quote/UCO.US.md) - [SPY.US](https://longbridge.com/en/quote/SPY.US.md) - [BNO.US](https://longbridge.com/en/quote/BNO.US.md) - [IVV.US](https://longbridge.com/en/quote/IVV.US.md) - [VOO.US](https://longbridge.com/en/quote/VOO.US.md) - [SPLG.US](https://longbridge.com/en/quote/SPLG.US.md) - [SPXL.US](https://longbridge.com/en/quote/SPXL.US.md) - [UPRO.US](https://longbridge.com/en/quote/UPRO.US.md) - [SSO.US](https://longbridge.com/en/quote/SSO.US.md) - [SH.US](https://longbridge.com/en/quote/SH.US.md) - [SPXS.US](https://longbridge.com/en/quote/SPXS.US.md) - [SPXU.US](https://longbridge.com/en/quote/SPXU.US.md) - [SDS.US](https://longbridge.com/en/quote/SDS.US.md) - [SPYI.US](https://longbridge.com/en/quote/SPYI.US.md) - [JEPI.US](https://longbridge.com/en/quote/JEPI.US.md) - [XYLD.US](https://longbridge.com/en/quote/XYLD.US.md) - [DIA.US](https://longbridge.com/en/quote/DIA.US.md) - [DDM.US](https://longbridge.com/en/quote/DDM.US.md) - [UDOW.US](https://longbridge.com/en/quote/UDOW.US.md) - [DOG.US](https://longbridge.com/en/quote/DOG.US.md) - [SDOW.US](https://longbridge.com/en/quote/SDOW.US.md) - [DXD.US](https://longbridge.com/en/quote/DXD.US.md) - [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md) - [ROIV.US](https://longbridge.com/en/quote/ROIV.US.md) - [PHVS.US](https://longbridge.com/en/quote/PHVS.US.md) - [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md) - [00HSI.HK](https://longbridge.com/en/quote/00HSI.HK.md) - [000001.CN](https://longbridge.com/en/quote/000001.CN.md) - [NOT.DE](https://longbridge.com/en/quote/NOT.DE.md) - [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md) ## Related News & Research - [What Dyne Therapeutics Stock One Year Trial Data Means For Shareholders](https://longbridge.com/en/news/299274984.md) - [Did Earnings Beat Just Shift ABM Industries' Stock Investment Narrative?](https://longbridge.com/en/news/298562996.md) - [Deutsche Bank Sticks to Its Hold Rating for Novartis AG (NOVN)](https://longbridge.com/en/news/299031862.md) - [Novartis: More pain on the way?](https://longbridge.com/en/news/298774732.md) - [Should Multiple Sclerosis Trial Win Require Action From Novartis (SWX:NOVN) Investors?](https://longbridge.com/en/news/299092670.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**